ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Refine Pharma Ltd

Refine Pharma Ltd is an active company incorporated on 8 November 2021 with the registered office located in Bolton, Greater Manchester. Refine Pharma Ltd was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13729940
Private limited company
Age
4 years
Incorporated 8 November 2021
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 22 January 2026 (1 day ago)
Next confirmation dated 22 January 2027
Due by 5 February 2027 (1 year remaining)
Last change occurred 1 day ago
Accounts
Submitted
For period 1 Dec30 Nov 2024 (1 year)
Accounts type is Unaudited Abridged
Next accounts for period 30 November 2025
Due by 31 August 2026 (7 months remaining)
Contact
Address
80 St. Georges Road
Bolton
BL1 2DD
England
Address changed on 28 Jan 2025 (12 months ago)
Previous address was 34 All Saints Street Bolton BL1 2ER United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
PSC • Director • British • Lives in England • Born in Oct 1995
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Refine BS Holdings Limited
Bradley Steven Tyson is a mutual person.
Active
Kbal Ltd
Bradley Steven Tyson is a mutual person.
Active
Gold Meriwether Ltd
Bradley Steven Tyson is a mutual person.
Dissolved
Bridge Medical Limited
Bradley Steven Tyson is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
30 Nov 2024
For period 30 Nov30 Nov 2024
Traded for 12 months
Cash in Bank
£379.05K
Increased by £210.48K (+125%)
Turnover
Unreported
Same as previous period
Employees
9
Increased by 2 (+29%)
Total Assets
£1.94M
Decreased by £263.23K (-12%)
Total Liabilities
-£1.61M
Decreased by £450.02K (-22%)
Net Assets
£328.64K
Increased by £186.8K (+132%)
Debt Ratio (%)
83%
Decreased by 10.49% (-11%)
Latest Activity
Confirmation Submitted
1 Day Ago on 22 Jan 2026
Refine Bs Holdings Limited (PSC) Appointed
1 Day Ago on 22 Jan 2026
Refine Bs Holdings Limited Details Changed
1 Day Ago on 22 Jan 2026
Bradley Tyson (PSC) Resigned
1 Day Ago on 22 Jan 2026
Mr Bradley Tyson (PSC) Details Changed
1 Month Ago on 2 Dec 2025
Confirmation Submitted
1 Month Ago on 2 Dec 2025
Jarnail Singh Kang (PSC) Resigned
1 Month Ago on 2 Dec 2025
Confirmation Submitted
2 Months Ago on 11 Nov 2025
Abridged Accounts Submitted
4 Months Ago on 28 Aug 2025
Jarnail Singh Kang Resigned
6 Months Ago on 1 Jul 2025
Get Credit Report
Discover Refine Pharma Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 22 January 2026 with updates
Submitted on 22 Jan 2026
Notification of Refine Bs Holdings Limited as a person with significant control on 22 January 2026
Submitted on 22 Jan 2026
Director's details changed for Refine Bs Holdings Limited on 22 January 2026
Submitted on 22 Jan 2026
Cessation of Bradley Tyson as a person with significant control on 22 January 2026
Submitted on 22 Jan 2026
Cessation of Jarnail Singh Kang as a person with significant control on 2 December 2025
Submitted on 2 Dec 2025
Confirmation statement made on 2 December 2025 with updates
Submitted on 2 Dec 2025
Change of details for Mr Bradley Tyson as a person with significant control on 2 December 2025
Submitted on 2 Dec 2025
Confirmation statement made on 7 November 2025 with no updates
Submitted on 11 Nov 2025
Unaudited abridged accounts made up to 30 November 2024
Submitted on 28 Aug 2025
Termination of appointment of Jarnail Singh Kang as a director on 1 July 2025
Submitted on 1 Jul 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year